Video

RF Versus ACPA in Assessing Rheumatoid Arthritis

(VIDEO) With rising attention to anti-citrullinated protein antibodies (ACPA) in RA classification, what is the current significance of rheumatoid factor? Rheumatologist Josef Smolen tells how he and others at the Medical University of Vienna addressed the question.

Two autoantibodies, rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA), compete for your attention in assessing the severity of rheumatoid arthritis. In this video from the American College of Rheumatology annual meeting , Dr. Josef Smolen describes the study in which they addressed the impact of ACPA on the need to assess RF.

You can read details of the study online. It's Abstract #421 in the ACR Abstract Supplement.

 

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.